About Vanta Bioscience
Vanta Bioscience is a company based in Chennai (India) founded in 2010 was acquired by Aragen in November 2014. The company has 43 employees as of March 22, 2024. Vanta Bioscience offers products and services including Discovery Toxicology, Agro-chemicals and Chemical Safety, Biocompatibility Studies, Diet Formulation, and Batch Release Test. Vanta Bioscience operates in a competitive market with competitors including Gentronix, Tigermed, Shanghai Semero Biotechnology, Gubra and BioQual, among others.
- Headquarter Chennai, India
- Employees 43 as on 22 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vanta Bioscience Ltd.
-
Annual Revenue
$229.89 K (USD)-79.8as on Mar 31, 2025
-
Net Profit
-$558.91 K (USD)-106.18as on Mar 31, 2025
-
EBITDA
-$498.16 K (USD)-419.5as on Mar 31, 2025
-
Latest Funding Round
Not available
- Investors
-
Employee Count
43
as on Mar 22, 2024
-
Acquired by
Aragen
(Nov 06, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Vanta Bioscience
Vanta Bioscience is a publicly listed company on the BSE with ticker symbol VANTABIO in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Vanta Bioscience
Vanta Bioscience offers a comprehensive portfolio of products and services, including Discovery Toxicology, Agro-chemicals and Chemical Safety, Biocompatibility Studies, Diet Formulation, and Batch Release Test.
Preclinical testing for drug safety and toxicity evaluation
Evaluation of safety for agrochemical products
Assessment of material compatibility for medical devices
Development of specialized diets for research studies
Testing for batch quality in pharmaceutical products
People of Vanta Bioscience
Unlock access to complete
Unlock access to complete
Funding Insights of Vanta Bioscience
Detailed funding history for Vanta Bioscience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Vanta Bioscience
Vanta Bioscience has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Aragen Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Aragen Life Sciences is engaged in contract research and manufacturing for pharmaceuticals.
|
Locked | Locked | Locked |
Investor details for Vanta Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vanta Bioscience
Investment portfolio details for Vanta Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vanta Bioscience
Detailed financials for Vanta Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vanta Bioscience Comparisons
Peer comparison for Vanta Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vanta Bioscience
Vanta Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gentronix, Tigermed, Shanghai Semero Biotechnology, Gubra and BioQual, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
In-vitro and in-vivo genetic toxicology screening services are provided.
|
|
| Locked | Locked | Locked |
Drug development and preclinical services are provided by Tigermed.
|
|
| Locked | Locked | Locked |
Diversified preclinical services for brain-related disorders are provided.
|
|
| Locked | Locked | Locked |
Preclinical CRO services for NAFLD/NASH, diabetes, and obesity are provided.
|
|
| Locked | Locked | Locked |
Contract research on infectious disease models is conducted.
|
|
| Locked | Locked | Locked |
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
|
Detailed competitors of Vanta Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vanta Bioscience
Complete news archive for Vanta Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vanta Bioscience
Vanta Bioscience was founded in 2010.
Vanta Bioscience is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
As of Mar 22, 2024, the latest employee count at Vanta Bioscience is 43.
Annual revenue of Vanta Bioscience is $229.89K as on Mar 31, 2025.
Vanta Bioscience was founded in 2010 in Chennai, India. Preclinical contract research services, certified under GLP standards, are offered to pharmaceutical, biotech, medical device, cosmetics, and chemical industries. Toxicology studies, biocompatibility assessments, and diet formulation services are included. A state-of-the-art research facility is maintained in compliance with international guidelines for animal care and use, with relevant accreditations ensuring adherence to regulatory requirements.
Vanta Bioscience offers Discovery Toxicology, Agro-chemicals and Chemical Safety, Biocompatibility Studies, Diet Formulation, and Batch Release Test.
Yes, Vanta Bioscience is publicly traded on BSE under the ticker symbol VANTABIO.
Vanta Bioscience has 1 investor. Key investors include Aragen Life Sciences.
The ticker symbol of Vanta Bioscience is VANTABIO on BSE.